Skip to main content
. 2022 Dec 1;482(1):131–145. doi: 10.1007/s00428-022-03460-y

Table 3.

Features of conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL). Data from [64]

Feature cMCL nnMCL
Translocations CCND1, CCND2 or CCND3 CCND1, CCND2 or CCND3
Lymphadenopathy Yes No/minimal
SOX11 +  Yes No/minimal
IGHV mutations No/limited Yes
Genomic complexity High Low
ATM aberration Frequent (40–50%) No
CCND1 mutation No Yes
TP53 aberrations 15–20% 20–30%